Measuring albumin breakdown in liver health
Part of Digestive system clinical trials.
This study measures how fast your body breaks down albumin, a protein made by the liver, using a safe tracer called a stable isotope. It compares healthy people with those who have liver cirrhosis to better understand liver function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 40 or older (healthy volunteers)
- You have compensated liver cirrhosis with signs of portal hypertension (like varices or enlarged spleen)
- You have good veins in your arms for blood draws
- You are not pregnant at the time of the study dose
- You have not taken part in another study with stable isotopes within the last 60 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether changes in a protein called albumin can help find liver disease earlier. It is for people who have some liver scarring but no serious complications.
This study looks at how your body uses protein in your muscles when you have cirrhosis (a scarred liver). It uses a special “tracer” method (a substance that can be tracked) and may help researchers better understand muscle loss in people with milder cirrhosis.
This study looks at how blood clotting, inflammation, and blood vessels change in people with chronic liver disease or cirrhosis. Your blood tests may help researchers understand what drives the disease and could guide future care.
This study looks at how the liver's mitochondria (the energy powerhouses of cells) work in people with fatty liver disease. Participants will have an MRI scan and receive a small amount of fat solution through an IV to see how the liver processes fat.
This study looks at how alcoholic liver disease may change a natural body clean-up process in muscle. It compares people with alcoholic liver disease to people without it to better understand the biology and identify possible targets for treatment.
This study is looking for a better way to diagnose and track chronic liver disease without invasive procedures like biopsies. If you join, researchers will use simple tests (like blood tests or imaging) to see how well they predict the progression of your liver condition.
Hear when a new Liver Disease Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.